Ginkgo Bioworks Holdings Inc.(DNA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

DNA Ginkgo Bioworks Holdings Inc.

Post-Mkt 12-11 18:33:56 EST

9.90

+0.12

+1.23%

盘后9.97

+0.07+0.70%

18:26 EST

High9.98	Low9.39	Vol974.19K
Open9.78	D1 Closing9.78	Amplitude6.03%
Mkt Cap599.84M	Tradable Cap411.22M	Total Shares60.59M
T/O9.50M	T/O Rate2.35%	Tradable Shares41.54M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"DNA","market":"US","secType":"STK","nameCN":"Ginkgo Bioworks Holdings Inc.","latestPrice":9.9,"timestamp":1765486800000,"preClose":9.78,"halted":0,"volume":974192,"hourTrading":{"tag":"盘后","latestPrice":9.9691,"preClose":9.9,"latestTime":"18:26 EST","volume":22285,"amount":220908.865075,"timestamp":1765495599974},"delay":0,"floatShares":41536899,"shares":60590219,"eps":-6.213238,"marketStatus":"Post-Mkt","change":0.12,"latestTime":"12-11 18:33:56 EST","open":9.78,"high":9.9799,"low":9.39,"amount":9497088.989136,"amplitude":0.060317,"askPrice":10.1,"askSize":100,"bidPrice":9.13,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-6.213238,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1765501200000},"marketStatusCode":4,"adr":0,"exchange":"NYSE","adjPreClose":9.78,"preHourTrading":{"tag":"盘前","latestPrice":9.791,"preClose":9.78,"latestTime":"09:29 EST","volume":7177,"amount":71717.191634,"timestamp":1765463378085},"postHourTrading":{"tag":"盘后","latestPrice":9.9691,"preClose":9.9,"latestTime":"18:26 EST","volume":22285,"amount":220908.865075,"timestamp":1765495599974},"volumeRatio":0.898039,"impliedVol":0.82,"impliedVolPercentile":0.076},"requestUrl":"/m/hq/s/DNA/wiki","defaultTab":"wiki","newsList":[{"id":"2590347079","title":"Ginkgo Bioworks Partners With Deep Origin-Led Team on ARPA-H to Develop Drug Safety Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2590347079","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590347079?lang=en_us&edition=fundamental","pubTime":"2025-12-09 23:26","pubTimestamp":1765293967,"startTime":"0","endTime":"0","summary":"Ginkgo Bioworks  said Tuesday it is partnering with Deep Origin on a 4.5-year project funded by advanced Research Projects Agency for Health, or ARPA-H, to develop a computational platform for predicting drug safety.Under the collaboration, Ginkgo Bioworks said it will use its Datapoints platform to produce high-throughput data sets for training AI models, including small-molecule and genetic perturbation data across multiple cell and tissue types.Readouts will include cell type-specific toxicity endpoints, transcriptomics and cell-painting, the company said.Price: 9.52, Change: +0.12, Percent Change: +1.22","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DNA","BK4139","DNA.AU","BK7078","BK4121","TISI","BK4120","BK4109"],"gpt_icon":0},{"id":"2589909448","title":"BRIEF-Ginkgo Bioworks Holdings Inc - Selected By Pnnl To Deliver A Modular, High‑Throughput Phenotyping Platform For Doe's M2pc","url":"https://stock-news.laohu8.com/highlight/detail?id=2589909448","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589909448?lang=en_us&edition=fundamental","pubTime":"2025-12-05 21:37","pubTimestamp":1764941879,"startTime":"0","endTime":"0","summary":"BRIEF-Ginkgo Bioworks Holdings Inc - Selected By Pnnl To Deliver A Modular, HighThroughput Phenotyping Platform For Doe's M2pcDec 5 (Reuters) - Ginkgo Bioworks Holdings Inc DNA.N:GINKGO BIOWORKS HOLDI","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nFWN3XB0HU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DNA","BK4109","BK4121"],"gpt_icon":0},{"id":"2589910890","title":"Ginkgo Bioworks Holdings Inc - Awarded by Environmental Molecular Sciences Laboratory a Four-Year, up to $47M Contract","url":"https://stock-news.laohu8.com/highlight/detail?id=2589910890","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589910890?lang=en_us&edition=fundamental","pubTime":"2025-12-05 21:35","pubTimestamp":1764941743,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nFWN3XB0HU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","DNA","BK4139","BK4109"],"gpt_icon":0},{"id":"2589890950","title":"Ginkgo Bioworks Holdings Inc - Selected by Pnnl to Deliver a Modular, High‑Throughput Phenotyping Platform for Doe's M2PC","url":"https://stock-news.laohu8.com/highlight/detail?id=2589890950","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589890950?lang=en_us&edition=fundamental","pubTime":"2025-12-05 21:35","pubTimestamp":1764941743,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nFWN3XB0HU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4121","DNA","BK4109"],"gpt_icon":0},{"id":"2589673890","title":"Ginkgo Bioworks Wins Up to $47 Million Contract to Build Automated Phenotyping Platform for PNNL","url":"https://stock-news.laohu8.com/highlight/detail?id=2589673890","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589673890?lang=en_us&edition=fundamental","pubTime":"2025-12-05 21:34","pubTimestamp":1764941673,"startTime":"0","endTime":"0","summary":"Ginkgo Bioworks Holdings Inc. announced it has been awarded a four-year contract worth up to $47 million by the Environmental Molecular Sciences Laboratory at Pacific Northwest National Laboratory. Under the agreement, Ginkgo will co-design, build, and integrate a High-Throughput Automated Phenotyping Platform to support the Department of Energy's Microbial Molecular Phenotyping Capability. The platform aims to enable large-scale, reproducible microbial and microbiome data generation and will utilize Ginkgo Automation's Catalyst scheduling software and modular Reconfigurable Automation Carts. The initiative is intended to enhance phenotyping throughput, support AI/ML applications, and provide a scalable foundation for future research instrumentation and workflows.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nNDL66ht8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4109","DNA","BK4121","BK4139"],"gpt_icon":0},{"id":"2589783924","title":"Is Twist’s New Endotoxin‑Controlled Plasmid DNA Offering Altering The Investment Case For TWST?","url":"https://stock-news.laohu8.com/highlight/detail?id=2589783924","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589783924?lang=en_us&edition=fundamental","pubTime":"2025-12-05 00:18","pubTimestamp":1764865137,"startTime":"0","endTime":"0","summary":"Twist Bioscience recently launched research-grade Plasmid DNA Preps to support pharmaceutical and biotech customers’ preclinical studies, offering animal origin-free and low or endotoxin-free, transfection-grade options with precise target yields from 4ug to 10ug.\nThis move underscores Twist’s effort to become a more integrated partner in nucleic acid therapeutics discovery by reducing variability and quality risk for customers’ sensitive cell-based workflows.\nNext, we’ll examine how Twist’s...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-twst/twist-bioscience/news/is-twists-new-endotoxincontrolled-plasmid-dna-offering-alter","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-twst/twist-bioscience/news/is-twists-new-endotoxincontrolled-plasmid-dna-offering-alter","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BK4585","TWST","DNA","BK4121","BK4139","BK4109"],"gpt_icon":0},{"id":"2588887713","title":"Twist Bioscience Introduces New Plasmid DNA Preparation Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2588887713","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588887713?lang=en_us&edition=fundamental","pubTime":"2025-12-04 22:07","pubTimestamp":1764857225,"startTime":"0","endTime":"0","summary":"Twist Bioscience  said Thursday it launched animal-origin-free and transfection-grade plasmid DNA preparation products for nucleic acid therapeutics research.The new products are designed to meet specific quality needs for preclinical studies, including low or endotoxin-free requirements for work involving sensitive cells, according to Twist.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4109","BK4121","TWST","DNA","BK4588","BK4585"],"gpt_icon":0},{"id":"2588075046","title":"Ginkgo Bioworks Joins STRM.BIO-Led Consortium to Advance In Vivo CAR-T Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2588075046","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588075046?lang=en_us&edition=fundamental","pubTime":"2025-12-03 21:01","pubTimestamp":1764766884,"startTime":"0","endTime":"0","summary":"Ginkgo Bioworks Holdings Inc. has entered into a collaboration with STRM.BIO, the University of British Columbia , and Advanced Bioprocess Services  to advance the development of in vivo CAR-T therapeutics. This partnership is supported by an ARPA-H contract awarded to STRM.BIO under the EMBODY program, with up to $8.4 million in funding for the first phase. Ginkgo Bioworks will contribute its expertise in RNA construct design and immune cell engineering to help develop STRM.BIO's megakaryocyte-derived extracellular vesicle delivery platform, aiming to create innovative, non-viral approaches to cell and gene therapy.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ginkgo Bioworks Holdings Inc. published the original content used to gene","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nNDL103sHN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNA","BK4121","BK4139","BK4109"],"gpt_icon":0},{"id":"2588056701","title":"Miss These Genesis Mission Stocks, and You’ll Regret It for a Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2588056701","media":"InvestorPlace","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588056701?lang=en_us&edition=fundamental","pubTime":"2025-12-02 21:55","pubTimestamp":1764683700,"startTime":"0","endTime":"0","summary":"The government is taking equity stakes in American companies. Here are the next Genesis Mission stocks to buy before the capital hits.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"investorplace_stock_picks","url":"https://investorplace.com/hypergrowthinvesting/2025/12/miss-these-genesis-mission-stocks-and-youll-regret-it-for-a-decade/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://investorplace.com/hypergrowthinvesting/2025/12/miss-these-genesis-mission-stocks-and-youll-regret-it-for-a-decade/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investorplace_stock_picks","symbols":["LU0274383776.USD","RGTI","MP","NVDY","3NVD.UK","ABSI","LU1429558221.USD","SNVD.UK","SLI","NVDL","TMQ","NVD2.UK","BWXT","ROIC","LU0265550359.USD","CEG","OKLO","LU2023251221.USD","NVDS.UK","SGXZ31699556.SGD","NVD","QBTS","WOLF","HON","SMR","TER","AI","2NVD.UK","TMO","NVIW.SI","ROK","DNA","MU","LAC","LEU","PPTA","NVDX","NNE","IONQ","NVD3.UK","NVDA","RXRX","INTC","NVDD","NVDS","NVDU","SKYT","TWST","SYM","SDGR"],"gpt_icon":0},{"id":"2587756423","title":"We Think OKP Holdings (SGX:5CF) Might Have The DNA Of A Multi-Bagger","url":"https://stock-news.laohu8.com/highlight/detail?id=2587756423","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587756423?lang=en_us&edition=fundamental","pubTime":"2025-11-29 06:01","pubTimestamp":1764367303,"startTime":"0","endTime":"0","summary":"Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/3041000-choice1-main-header/1585186744280","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3041000-choice1-main-header/1585186744280"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/sg/capital-goods/sgx-5cf/okp-holdings-shares/news/we-think-okp-holdings-sgx5cf-might-have-the-dna-of-a-multi-b","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/sg/capital-goods/sgx-5cf/okp-holdings-shares/news/we-think-okp-holdings-sgx5cf-might-have-the-dna-of-a-multi-b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["5CF.SI","BK4109","BK6520","BK6045","DNA","EBIT","BK4121","BK4139"],"gpt_icon":0},{"id":"2584929653","title":"Ginkgo Bioworks Q3 Net Income USD -80.755 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2584929653","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584929653?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:58","pubTimestamp":1763571483,"startTime":"0","endTime":"0","summary":"Nov 06 (Reuters) - Ginkgo Bioworks Q3 operating expenses USD 128.854 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 06-NOV-202521:05:46.91 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD2vzgxD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4109","DNA","BK4139"],"gpt_icon":0},{"id":"2584599956","title":"Ginkgo Bioworks Collaborating With Institute for Genomic Biology on Oral Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2584599956","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584599956?lang=en_us&edition=fundamental","pubTime":"2025-11-18 22:55","pubTimestamp":1763477739,"startTime":"0","endTime":"0","summary":"Ginkgo Bioworks  said Tuesday it has formed a partnership with the Institute for Genomic Biology at the University of Illinois Urbana-Champaign  to develop new oral health treatments.The company said it will use its EncapS technology for ultra-high-throughput screening to identify and evaluate phage-based interventions targeting specific bacteria in the oral microbiome.Ginkgo Bioworks' shares were 2% lower in recent trading.Price: 7.63, Change: -0.14, Percent Change: -1.80","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4109","BK4139","BK4121","DNA.AU","DNA","BK7078"],"gpt_icon":0},{"id":"2584721316","title":"Applied DNA Sciences Rebrands to BNB Plus Corp.","url":"https://stock-news.laohu8.com/highlight/detail?id=2584721316","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584721316?lang=en_us&edition=fundamental","pubTime":"2025-11-18 05:56","pubTimestamp":1763416596,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Applied DNA Sciences ( ($BNBX) ). On November 13, 2025, Applied DNA Sciences officially changed its name to BNB...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/applied-dna-sciences-rebrands-to-bnb-plus-corp?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/applied-dna-sciences-rebrands-to-bnb-plus-corp?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DNA","BK4121","BK4109","BK4139"],"gpt_icon":0},{"id":"2584626768","title":"Applied DNA chairperson Judy Murrah steps down, Josh Kruger to succeed","url":"https://stock-news.laohu8.com/highlight/detail?id=2584626768","media":"TIPRANKS","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584626768?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:26","pubTimestamp":1763385996,"startTime":"0","endTime":"0","summary":"Applied DNA (BNBX) announced that it will change its name to BNB Plus. Alongside the rebrand, the company also announced the appointment of Josh Kr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/applied-dna-chairperson-judy-murrah-steps-down-josh-kruger-to-succeed-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/applied-dna-chairperson-judy-murrah-steps-down-josh-kruger-to-succeed-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DNA"],"gpt_icon":0},{"id":"2582827914","title":"Institutional shareholders may be less affected by Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) pullback last week after a year of 2.2% returns","url":"https://stock-news.laohu8.com/highlight/detail?id=2582827914","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582827914?lang=en_us&edition=fundamental","pubTime":"2025-11-10 18:08","pubTimestamp":1762769319,"startTime":"0","endTime":"0","summary":"Key Insights Given the large stake in the stock by institutions, Ginkgo Bioworks Holdings' stock price might be...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-dna/ginkgo-bioworks-holdings/news/institutional-shareholders-may-be-less-affected-by-ginkgo-bi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-dna/ginkgo-bioworks-holdings/news/institutional-shareholders-may-be-less-affected-by-ginkgo-bi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","BK4109","BK4121","NYSE","DNA"],"gpt_icon":0},{"id":"1131194590","title":"Couple Dubbed \"Most Alike Online\" Respond to DNA Test Requests, Wife Shares Their Journey","url":"https://stock-news.laohu8.com/highlight/detail?id=1131194590","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131194590?lang=en_us&edition=fundamental","pubTime":"2025-11-09 12:30","pubTimestamp":1762662638,"startTime":"0","endTime":"0","summary":"A Guangdong-based couple in their 30s has gone viral for their striking resemblance, earning them the title of \"most alike couple online.\" In videos, the pair, dressed identically with similar facial...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNA","BK4139","BK4121","BK4109"],"gpt_icon":0},{"id":"2581685970","title":"Bank of America Securities Remains a Sell on Ginkgo Bioworks Holdings (DNA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2581685970","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581685970?lang=en_us&edition=fundamental","pubTime":"2025-11-08 13:35","pubTimestamp":1762580126,"startTime":"0","endTime":"0","summary":"In a report released yesterday, from Bank of America Securities maintained a Sell rating on Ginkgo Bioworks Holdings. The company’s shares closed y...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-sell-on-ginkgo-bioworks-holdings-dna-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-sell-on-ginkgo-bioworks-holdings-dna-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0098860793.USD","LU0417517546.SGD","LU1162221912.USD","LU0130517989.USD","BK4553","LU1883839398.USD","LU0868494617.USD","IE00B7SZLL34.SGD","LU0310800965.SGD","LU1363072403.SGD","IE00BFXG1179.USD","LU1496350171.SGD","LU0640476718.USD","LU0128525689.USD","LU2129689605.HKD","IE0002270589.USD","IE00B19Z3581.USD","LU1880398554.USD","LU0648001328.SGD","LU0053666078.USD","BAC","LU0648000940.SGD","DNA","LU1366192091.USD","LU0130518102.USD","IE00BZ1G4Q59.USD","IE00BBT3K403.USD","LU2265009873.SGD","BK4534","LU0203347892.USD","LU2133065610.SGD","LU0234572021.USD","LU0787776722.HKD","IE00BKVL7J92.USD","LU1506573853.SGD","LU0256863811.USD","LU1201861249.SGD","BK4109","BK4585","LU0971096721.USD","LU0477156797.USD","IE00B1BXHZ80.USD","LU1267930227.SGD","LU1280957306.USD","LU0052756011.USD","BK4559","LU1201861165.SGD","LU0477156953.USD","LU0320765489.SGD","LU0149725797.USD"],"gpt_icon":0},{"id":"2581836106","title":"James Watson, Who Codiscovered DNA Structure, Dies at 97 -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2581836106","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581836106?lang=en_us&edition=fundamental","pubTime":"2025-11-08 04:00","pubTimestamp":1762545600,"startTime":"0","endTime":"0","summary":"James Watson, the scientist who became famous for helping discover the structure of DNA in 1953 and notorious decades later for suggesting that Black people are intellectually inferior to whites, has died at age 97, according to a news release from Cold Spring Harbor Laboratory.Watson was 25 when he and English biophysicist Francis Crick figured out the double helix structure of DNA that encodes the essential information for life. The two shared the 1962 Nobel Prize in Physiology or Medicine with colleague Maurice Wilkins.The discovery made Watson one of the most influential figures in modern science. His later comments confounded colleagues and supporters. They called Watson's remarks a misuse of the very science that propelled his career.\"DNA made him who he was,\" said Nathaniel Comfort, a professor of the history of medicine at Johns Hopkins University who is writing a biography of Watson, \"and it undid him in the end.\"","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNA","BK4139","BK4109","BK4121"],"gpt_icon":0},{"id":"2581075010","title":"U.S. RESEARCH ROUNDUP-Blackline, Carmax, Expedia","url":"https://stock-news.laohu8.com/highlight/detail?id=2581075010","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581075010?lang=en_us&edition=fundamental","pubTime":"2025-11-07 14:57","pubTimestamp":1762498662,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Blackline, Carmax, ExpediaNov 7 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Blackline, Carmax a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nL4N3WJ0GS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMT","CELH","KMX","STZ","BILL","XYZ","NTLA","DDOG","BK4126","HUM","TXG","EFXT","LU0106261612.USD","AKAM","BK4585","EVH","LC","DSGN","EXPE","CCOI","ICUI","BHF","GEF","BK4162","EVCM","BDX","EXR","DNA","FA","LH","LU0985320562.USD","HAE","BK4504","APD","FIVN","AQST","FRGE","GMED","LU0205194284.USD","LU0240878834.USD","MTSI","EVTC","BK4548","FRSH","FROG","BL"],"gpt_icon":1},{"id":"2581783410","title":"Ginkgo Bioworks Holdings Inc : TD Cowen Cuts Target Price to $14 From $18","url":"https://stock-news.laohu8.com/highlight/detail?id=2581783410","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581783410?lang=en_us&edition=fundamental","pubTime":"2025-11-07 14:02","pubTimestamp":1762495372,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nFWN3WJ01T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DNA","BK4121","BK4109","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ginkgobioworks.com","stockEarnings":[{"period":"1week","weight":0.0855},{"period":"1month","weight":0.1152},{"period":"3month","weight":-0.0632},{"period":"6month","weight":0.094},{"period":"1year","weight":-0.1133},{"period":"ytd","weight":-0.0041}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.009},{"period":"3month","weight":0.0455},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1406},{"period":"ytd","weight":0.1732}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.012519},{"month":2,"riseRate":0.25,"avgChangeRate":-0.155171},{"month":3,"riseRate":0,"avgChangeRate":-0.186194},{"month":4,"riseRate":0.25,"avgChangeRate":-0.075483},{"month":5,"riseRate":0.4,"avgChangeRate":-0.028577},{"month":6,"riseRate":0.6,"avgChangeRate":0.042062},{"month":7,"riseRate":0.8,"avgChangeRate":0.169362},{"month":8,"riseRate":0.2,"avgChangeRate":-0.142535},{"month":9,"riseRate":0.8,"avgChangeRate":0.092966},{"month":10,"riseRate":0.2,"avgChangeRate":-0.069954},{"month":11,"riseRate":0.2,"avgChangeRate":-0.122886},{"month":12,"riseRate":0.6,"avgChangeRate":0.008405}],"exchange":"NYSE","name":"Ginkgo Bioworks Holdings Inc.","nameEN":"Ginkgo Bioworks Holdings Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ginkgo Bioworks Holdings Inc.(DNA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Ginkgo Bioworks Holdings Inc.(DNA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Ginkgo Bioworks Holdings Inc.,DNA,Ginkgo Bioworks Holdings Inc.股票,Ginkgo Bioworks Holdings Inc.股票老虎,Ginkgo Bioworks Holdings Inc.股票老虎国际,Ginkgo Bioworks Holdings Inc.行情,Ginkgo Bioworks Holdings Inc.股票行情,Ginkgo Bioworks Holdings Inc.股价,Ginkgo Bioworks Holdings Inc.股市,Ginkgo Bioworks Holdings Inc.股票价格,Ginkgo Bioworks Holdings Inc.股票交易,Ginkgo Bioworks Holdings Inc.股票购买,Ginkgo Bioworks Holdings Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ginkgo Bioworks Holdings Inc.(DNA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Ginkgo Bioworks Holdings Inc.(DNA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction